InvestorsHub Logo
Followers 8
Posts 328
Boards Moderated 0
Alias Born 11/06/2012

Re: GoldRus post# 74961

Wednesday, 05/29/2013 9:28:56 AM

Wednesday, May 29, 2013 9:28:56 AM

Post# of 158400
Yes, that is exactly how I think this has to be understood. BMSN responds to the FDA-questions in Q3. In order to be able (allowed) to start trials with Hemaxellerate in Q4 (as written in the PR), the FDA-approval has to take place somewhere in between theses two dates, IMO.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.